A new apoptotic pathway for the complement factor B-derived fragment Bb

Journal of Cellular Physiology

Volumn 185, Issue 2, 2000, Pages 280-292

  Uwai, Masaya ^a   Terui, Yasuhito ^a   Mishima, Yuji ^b   Tomizuka, Hiroshi ^a   Ikeda, Masayuki ^b   Itoh, Takehito ^b   Mori, Masaki ^a   Ueda, Masuzu ^a   Inoue, Rie ^e   Yamada, Muneo ^b   Hayasawa, Hirotoshi ^b   Horiuchi, Takahiko ^c   Niho, Yoshiyuki ^c   Matsumoto, Mitsuru ^d   Ishizaka, Yukihito ^e   Ikeda, Kazuma ^f   Ozawa, Keiya ^a   Hatake, Kiyohiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b MORINAGA MILK INDUSTRY CO LTD   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENTARY DNA; FAS ANTIGEN; FAS LIGAND; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL DEATH; CELL DIFFERENTIATION; CELL STRAIN K 562; COMPLEMENT SYSTEM; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; COMPLEMENT 3; COMPLEMENT 3B; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HL-60 CELLS; HUMAN; INTEGRIN ALPHAXBETA2; LEUKEMIA; LYMPHOMA; MEMBRANE GLYCOPROTEINS; PEPTIDE FRAGMENTS; PHORBOL 12,13-DIBUTYRATE; RECEPTORS, COMPLEMENT; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0033795417     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4652(200011)185:2<280::AID-JCP13>3.0.CO;2-L     Document Type: Article

References (47)

1. The Ba fragment of complement factor B inhibits human B lymphocyte proliferation
2. The atypical serine proteases of the complement system
3. The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b: Activation by a heterogenous β subunit and localization of a ligand recognition site to the I domain
4. In stroke, complement will get you nowhere
5. Mutation of residues in the C3dg region of human complement C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2
6. The role of C3 in the immune response
7. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b, Bb
8. Apoptosis in leukemic cells: Basic and clinical aspects
9. Human complement factor B: cDNA cloning, nucleotide sequencing, phenotypic conversion by site-directed mutagenesis and expression
10. A conserved element in the serine protease domain of complement factor B
11. Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding
12. Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis
13. Neuronal protection in stroke by an sLe(x)-glycosylated complement inhibitory protein
14. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide
15. Genetic deficiencies of the complement system and association with disease-early components
16. Isolation and characterization of a 33,000-dalton fragment of complement factor B with catalytic and C3b binding activity
17. Control of the complement system
18. CCAAT-enhancer-binding proteins (C/EBP) regulate the tissue specific activity of the CD11c integrin gene promoter through functional interactions with Sp1 proteins
19. PU.1 negatively regulates the CD11c integrin gene promoter through recognition of the major transcriptional start site
20. AP-1 regulates the basal and developmentally induced transcription of the CD11c leukocyte integrin gene
21. Abrogation of the alternative complement pathway by targeted deletion of murine factor B
22. A novel protein that participates in nonself discrimination of malignant cells by homologous complement
23. 2-microglobulin identified as an apoptosis-inducing factor and its characterization
24. Internal homologies of the Ba fragment from human complement component factor B, a class III MHC antigen
25. X-ray crystal structure of C3d: A C3 fragment and ligand for complement receptor 2
26. Apoptosis by death factor
27. Amino-terminal sequence of human factor B of the alternative complement pathway and its cleavage fragments, Ba and Bb
28. Regulation of the leukocyte integrin gene CD11c is mediated by AP1 and Ets transcription factors
29. Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription
30. Hematopoietic cell-type-dependent regulation of leukocyte integrin functional activity: CD11b and CD11c expression inhibits LFA-1-dependent aggregation of differentiated U937 cells
31. Radioassays for quantitation of intact complement proteins C2 and B in human serum
32. Expression of src-like adapter protein mRNA is induced by all-trans retinoic acid
33. Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35)
34. The Bb fragment of complement factor B acts as a B cell growth factor
35. Alternative complement pathway activation fragment Ba binds to C3b: Evidence that formation of the factor B-C3b complex involves two discrete points of contact
36. Proteolytic activity of the different fragments of factor B on the third component of complement (C3). Involvement of the N-terminal domain of Bb in magnesium binding
37. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines
38. Fas ligand in human serum
39. Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18)
40. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 α'-chain
41. A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45
42. Expression of differentiation-related phenotypes and apoptosis are independently regulated during myeloid cell differentiation
43. Identification of a novel apoptosis-inducing factor derived from leukemic cells: Endothelial interleukin-8, but not monocyte-derived, induces apoptosis in leukemic cells
44. Activated endothelial cells induce apoptosis in leukemic cells by endothelial interleukin-8
45. Probing functional sites on complement protein B with monoclonal antibodies. Evidence for C3b-binding sites on Ba
46. Cell-specific expression of the human complement protein factor B gene: Evidence for the role of two distinct 5'-flanking elements
47. Contribution of the complement control protein modules of C2 in C4b binding assessed by analysis of C2/ factor B chimeras